Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Schroeder

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Journal of Hematology & Oncology|January 8, 2024
The Association of Agent Orange Exposure with the progression of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based study of Vietnam War Era VeteransLawrence W Liu, Mei Wang, Nikhil Grandhi, et al.
Journal of Neurosurgery|September 25, 2007
Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapyEduard B Dinca, Jann N Sarkaria, Mark A Schroeder, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|October 22, 2008
Bioluminescent imaging of intracranial vestibular schwannoma xenografts in NOD/SCID miceBrian A Neff, Stephen G Voss, Cory Allen, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 23, 2019
Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass StudyScott R Goldsmith, Mark A Fiala, James Dukeman, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 30, 2020
The effect of donor type on outcomes in adults with acute myeloid leukemia after reduced-intensity hematopoietic peripheral blood cell transplant - a retrospective studyNahid Rashid, Michael Slade, Ramzi Abboud, et al.
Plos One|March 5, 2013
Targeting Src family kinases inhibits bevacizumab-induced glioma cell invasionDeborah Huveldt, Laura J Lewis-Tuffin, Brett L Carlson, et al.
Transplantation and Cellular Therapy|September 23, 2023
Continuous Elotuzumab, Pomalidomide, and Dexamethasone Maintenance Following Second Autologous Transplantation for Multiple Myeloma: Results of a Prospective Phase 2 Multicenter TrialMichael Slade, Mark A Fiala, Marie Kirchmeyer, et al.
Cancer Control : Journal of the Moffitt Cancer Center|December 22, 2025
Convenience Versus Continuity: A Pilot Study of Care Transfer to a Satellite Clinic for Patients With Plasma Cell DyscrasiasAngela M Vickroy, Margaret Kavanaugh, Jordan Smith, et al.
Journal of Neuro-Oncology|May 6, 2010
Expression of CD74 in high grade gliomas: a potential role in temozolomide resistanceGaspar J Kitange, Brett L Carlson, Mark A Schroeder, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 5, 2023
Venous Thromboembolism Risk in Patients With Newly Diagnosed Multiple Myeloma Treated with Carfilzomib or Bortezomib in Combination With Lenalidomide and DexamethasoneAlexa J Loncharich, Mark A Fiala, Michael J Slade, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Journal of Hematology & Oncology|January 8, 2024
The Association of Agent Orange Exposure with the progression of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based study of Vietnam War Era VeteransLawrence W Liu, Mei Wang, Nikhil Grandhi, et al.
Journal of Neurosurgery|September 25, 2007
Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapyEduard B Dinca, Jann N Sarkaria, Mark A Schroeder, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|October 22, 2008
Bioluminescent imaging of intracranial vestibular schwannoma xenografts in NOD/SCID miceBrian A Neff, Stephen G Voss, Cory Allen, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 23, 2019
Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass StudyScott R Goldsmith, Mark A Fiala, James Dukeman, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 30, 2020
The effect of donor type on outcomes in adults with acute myeloid leukemia after reduced-intensity hematopoietic peripheral blood cell transplant - a retrospective studyNahid Rashid, Michael Slade, Ramzi Abboud, et al.
Plos One|March 5, 2013
Targeting Src family kinases inhibits bevacizumab-induced glioma cell invasionDeborah Huveldt, Laura J Lewis-Tuffin, Brett L Carlson, et al.
Transplantation and Cellular Therapy|September 23, 2023
Continuous Elotuzumab, Pomalidomide, and Dexamethasone Maintenance Following Second Autologous Transplantation for Multiple Myeloma: Results of a Prospective Phase 2 Multicenter TrialMichael Slade, Mark A Fiala, Marie Kirchmeyer, et al.
Cancer Control : Journal of the Moffitt Cancer Center|December 22, 2025
Convenience Versus Continuity: A Pilot Study of Care Transfer to a Satellite Clinic for Patients With Plasma Cell DyscrasiasAngela M Vickroy, Margaret Kavanaugh, Jordan Smith, et al.
Journal of Neuro-Oncology|May 6, 2010
Expression of CD74 in high grade gliomas: a potential role in temozolomide resistanceGaspar J Kitange, Brett L Carlson, Mark A Schroeder, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 5, 2023
Venous Thromboembolism Risk in Patients With Newly Diagnosed Multiple Myeloma Treated with Carfilzomib or Bortezomib in Combination With Lenalidomide and DexamethasoneAlexa J Loncharich, Mark A Fiala, Michael J Slade, et al.
Pageof 11